(Q34718188)

4 August 2017

1 reference

title

Identification of tumour-associated T-cell epitopes for vaccine development (English)

1 reference

4 August 2017

1 reference

Stefan Stevanovic

1

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

4 August 2017

published in

Nature Reviews Cancer

1 reference

4 August 2017

volume

2

1 reference

4 August 2017

issue

7

1 reference

4 August 2017

page(s)

514-520

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc841

4 August 2017

exact match

0 references

cites work

A listing of human tumor antigens recognized by T cells

1 reference

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

31 March 2020

1 reference

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

31 March 2020

1 reference

Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100.

31 March 2020

1 reference

Short-term kinetics of tumor antigen expression in response to vaccination

31 March 2020

1 reference

HLA class I expression on human cancer cells. Implications for effective immunotherapy

31 March 2020

1 reference

SYFPEITHI: database for MHC ligands and peptide motifs

31 March 2020

1 reference

Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas

31 March 2020

1 reference

MAGE, BAGE and GAGE: tumour antigen expression in benign and malignant ovarian tissue

31 March 2020

1 reference

Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for tumor antigen-specific immunotherapy.

31 March 2020

1 reference

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

31 March 2020

1 reference

A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E

31 March 2020

1 reference

Lethality-based selection of recombinant genes in mammalian cells: application to identifying tumor antigens

31 March 2020

1 reference

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

31 March 2020

1 reference

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

31 March 2020

1 reference

Exact prediction of a natural T cell epitope

31 March 2020

1 reference

Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes

31 March 2020

1 reference

PAProC: a prediction algorithm for proteasomal cleavages available on the WWW.

31 March 2020

1 reference

Combining computer algorithms with experimental approaches permits the rapid and accurate identification of T cell epitopes from defined antigens

31 March 2020

1 reference

Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis.

31 March 2020

1 reference

Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach

31 March 2020

1 reference

Human neoplasms elicit multiple specific immune responses in the autologous host

31 March 2020

1 reference

Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer

31 March 2020

1 reference

Tumor-associated antigens identified by mRNA expression profiling induce protective anti-tumor immunity

31 March 2020

1 reference

Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array

31 March 2020

1 reference

Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial

31 March 2020

1 reference

A MAGE-1 peptide recognized on HLA-DR15 by CD4(+) T cells

31 March 2020

1 reference

Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity

31 March 2020

1 reference

A lysosomal targeting signal in the cytoplasmic tail of the beta chain directs HLA-DM to MHC class II compartments.

31 March 2020

1 reference

Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins

31 March 2020

1 reference

MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation

31 March 2020

1 reference

CD4(+) T cells induced by a DNA vaccine: immunological consequences of epitope-specific lysosomal targeting.

31 March 2020

1 reference

A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.

31 March 2020

1 reference

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes

31 March 2020

1 reference

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

31 March 2020

1 reference

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

31 March 2020

1 reference

A human CTL recognizes a caspase-8-derived peptide on autologous HLA-B*3503 molecules and two unrelated peptides on allogeneic HLA-B*3501 molecules

31 March 2020

1 reference

A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes

31 March 2020

1 reference

Dendritic cell-based immunotherapy of prostate cancer

31 March 2020

1 reference

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines

31 March 2020

1 reference

Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma.

31 March 2020

1 reference

Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM-CSF as adjuvant.

31 March 2020

1 reference

Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells

31 March 2020

1 reference

Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma.

31 March 2020

1 reference

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

31 March 2020

1 reference

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC841

1 reference

Dimensions Publication ID

4 August 2017

1011451363

0 references

1 reference